Get the Stockscreener App
17.92
2.11%
0.37
After Hours:
17.92
Innoviva Inc stock is traded at $17.92, with a volume of 634.72K.
It is up +2.11% in the last 24 hours and down -3.86% over the past month.
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
See More
Previous Close:
$17.55
Open:
$17.58
24h Volume:
634.72K
Relative Volume:
1.13
Market Cap:
$1.12B
Revenue:
$330.50M
Net Income/Loss:
$145.42M
P/E Ratio:
10.86
EPS:
1.65
Net Cash Flow:
$157.96M
1W Performance:
-0.88%
1M Performance:
-3.86%
6M Performance:
-7.53%
1Y Performance:
+17.28%
1-Day Range:
$17.46
$17.99
1-Week Range:
$17.46
$18.57
52-Week Range:
$14.32
$21.28
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
17.92 | 1.12B | 330.50M | 145.42M | 157.96M | 1.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
479.79 | 123.21B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
698.74 | 76.39B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
624.67 | 37.96B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.75 | 31.94B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
271.80 | 29.00B | 3.32B | -860.46M | -1.04B | -8.32 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-20-22 | Initiated | Goldman | Neutral |
| Nov-20-17 | Initiated | Deutsche Bank | Hold |
Innoviva Inc Stock (INVA) Latest News
Innoviva, Inc. (NASDAQ:INVA) Shares Sold by Denali Advisors LLC - MarketBeat
When the Price of (INVA) Talks, People Listen - Stock Traders Daily
Innoviva, Inc. to Host Earnings Call - ACCESS Newswire
Innoviva (NASDAQ:INVA) Releases Earnings Results - MarketBeat
Innoviva (INVA) to Release Quarterly Earnings on Thursday - MarketBeat
Innoviva (INVA) to Release Earnings on Thursday - Defense World
Innoviva: Q4 Earnings Snapshot - Thehour.com
Innoviva, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Innoviva Reports Fourth Quarter and Full Year 2024 Financial Results; Highlights Recent Company Progress - BioSpace
Innoviva Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings Flash (INVA) INNOVIVA INC. Posts Q4 Revenue $91.8M, vs. FactSet Est of $86.8M - Marketscreener.com
Can Innoviva's 47% Specialty Therapeutics Growth Offset Declining GSK Royalties? - StockTitan
Hussman Strategic Advisors Inc. Increases Stock Position in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Allspring Global Investments Holdings LLC Cuts Stock Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva: Underappreciated Strength In Hospital Therapeutics (NASDAQ:INVA) - Seeking Alpha
StockNews.com Downgrades Innoviva (NASDAQ:INVA) to Hold - Defense World
Innoviva, Inc. (NASDAQ:INVA) Short Interest Update - MarketBeat
Short Interest in Innoviva, Inc. (NASDAQ:INVA) Declines By 10.2% - Defense World
Entropy Technologies LP Invests $248,000 in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
(INVA) Investment Analysis - Stock Traders Daily
Innoviva (NASDAQ:INVA) Lowered to Hold Rating by StockNews.com - Defense World
Innoviva (INVA) Shares Cross Below 200 DMA - Nasdaq
Innoviva (NASDAQ:INVA) Rating Increased to Buy at StockNews.com - MarketBeat
Innoviva (NASDAQ:INVA) Stock Rating Upgraded by StockNews.com - Defense World
(INVA) Investment Report - Stock Traders Daily
Ratio Review: Analyzing Innoviva Inc (INVA)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Innoviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire
Healthcare Watch: Innoviva's Strategic Vision Takes Center Stage at Major Oppenheimer Conference - StockTitan
Innoviva, Inc. (NASDAQ:INVA) Shares Bought by Pacer Advisors Inc. - MarketBeat
Franklin Resources Inc Reduces Stake in Innoviva Inc - GuruFocus.com
Brokers Set Expectations for Innoviva FY2025 Earnings - Defense World
Cantor Fitzgerald Comments on Innoviva FY2025 Earnings - MarketBeat
Innoviva (NASDAQ:INVA) investors are up 4.7% in the past week, but earnings have declined over the last five years - Simply Wall St
When (INVA) Moves Investors should Listen - Stock Traders Daily
JPMorgan Chase & Co. Has $11.17 Million Stake in Innoviva, Inc. (NASDAQ:INVA) - Defense World
JPMorgan Chase & Co. Acquires 72,039 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Armata Pharmaceuticals Announces $35 Million Secured Credit Agre - GuruFocus.com
(INVA) Trading Report - Stock Traders Daily
Principal Financial Group Inc. Cuts Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva (NASDAQ:INVA) Downgraded to “Hold” Rating by StockNews.com - Defense World
Innoviva (NASDAQ:INVA) Downgraded to Hold Rating by StockNews.com - MarketBeat
Barclays PLC Purchases 72,192 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Geode Capital Management LLC Has $26.22 Million Stake in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Barclays PLC Acquires 72,192 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Trading (INVA) With Integrated Risk Controls - Stock Traders Daily
Stock Gains You Can't Ignore! - Jomfruland.net
Innoviva's (NASDAQ:INVA) investors will be pleased with their 26% return over the last five years - Yahoo Finance
MML Investors Services LLC Buys 2,985 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Bought by Jane Street Group LLC - Defense World
Jane Street Group LLC Increases Position in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Fmr LLC Buys 771 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):